Wird geladen...
Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain
BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/ https://ncbi.nlm.nih.gov/pubmed/24314138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|